MEDICINOVA INC's ticker is MNOV and the CUSIP is 58468P206. A total of 22 filers reported holding MEDICINOVA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $99,896 | -36.0% | 69,372 | -35.6% | 0.00% | – |
Q1 2024 | $156,156 | -31.7% | 107,694 | -29.4% | 0.00% | – |
Q4 2023 | $228,796 | -30.7% | 152,530 | -3.4% | 0.00% | – |
Q3 2023 | $330,100 | +25.0% | 157,942 | +37.6% | 0.00% | – |
Q2 2023 | $263,978 | +11.1% | 114,773 | +4.3% | 0.00% | – |
Q1 2023 | $237,678 | +155245.1% | 110,036 | +46.7% | 0.00% | – |
Q4 2022 | $153 | -99.8% | 75,005 | +62.7% | 0.00% | – |
Q3 2022 | $100,000 | -18.7% | 46,099 | -5.3% | 0.00% | – |
Q2 2022 | $123,000 | -8.9% | 48,674 | -3.8% | 0.00% | – |
Q1 2022 | $135,000 | -8.2% | 50,574 | -7.8% | 0.00% | – |
Q4 2021 | $147,000 | -29.0% | 54,855 | +0.6% | 0.00% | – |
Q3 2021 | $207,000 | +107.0% | 54,532 | +132.3% | 0.00% | – |
Q2 2021 | $100,000 | -27.5% | 23,470 | -13.9% | 0.00% | – |
Q1 2021 | $138,000 | +11.3% | 27,264 | +15.7% | 0.00% | – |
Q4 2020 | $124,000 | -3.1% | 23,564 | -3.5% | 0.00% | – |
Q3 2020 | $128,000 | +17.4% | 24,427 | +21.7% | 0.00% | – |
Q2 2020 | $109,000 | +186.8% | 20,069 | +98.5% | 0.00% | – |
Q1 2020 | $38,000 | -83.0% | 10,110 | -71.2% | 0.00% | – |
Q3 2017 | $223,000 | -52.0% | 35,060 | -60.3% | 0.00% | – |
Q2 2017 | $465,000 | -19.1% | 88,314 | -8.0% | 0.00% | – |
Q1 2017 | $575,000 | -8.7% | 95,974 | -8.1% | 0.00% | – |
Q4 2016 | $630,000 | -46.7% | 104,415 | -33.8% | 0.00% | -100.0% |
Q3 2016 | $1,182,000 | -11.8% | 157,805 | -11.1% | 0.00% | 0.0% |
Q2 2016 | $1,340,000 | -2.0% | 177,527 | -4.8% | 0.00% | 0.0% |
Q1 2016 | $1,368,000 | +96.3% | 186,411 | -5.1% | 0.00% | – |
Q4 2015 | $697,000 | +7.6% | 196,460 | -13.9% | 0.00% | – |
Q3 2015 | $648,000 | -30.7% | 228,157 | -3.6% | 0.00% | -100.0% |
Q2 2015 | $935,000 | +9.7% | 236,600 | -2.3% | 0.00% | 0.0% |
Q1 2015 | $852,000 | +14.7% | 242,177 | -0.9% | 0.00% | – |
Q4 2014 | $743,000 | +0.8% | 244,326 | -0.9% | 0.00% | -100.0% |
Q3 2014 | $737,000 | +45.4% | 246,475 | -1.3% | 0.00% | – |
Q2 2014 | $507,000 | -5.8% | 249,794 | -3.9% | 0.00% | – |
Q1 2014 | $538,000 | -4.4% | 259,817 | -1.2% | 0.00% | – |
Q4 2013 | $563,000 | -15.1% | 263,034 | 0.0% | 0.00% | -100.0% |
Q3 2013 | $663,000 | -4.5% | 263,034 | -0.3% | 0.00% | 0.0% |
Q2 2013 | $694,000 | – | 263,719 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 1,170,370 | $2,376,000 | 0.49% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 40,000 | $81,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 47,646 | $96,000 | 0.00% |
BlackRock Investment Management, LLC | 3,590 | $7,000 | 0.00% |
MACQUARIE GROUP LTD | 32 | $0 | 0.00% |
Citadel Advisors | 15,273 | $31,000 | 0.00% |
WEALTHFRONT Corp | 190 | $0 | 0.00% |
Tower Research Capital LLC (TRC) | 100 | $0 | 0.00% |
MORGAN STANLEY | 138 | $0 | 0.00% |
BlackRock Institutional Trust Company, N.A. | 132,149 | $268,000 | 0.00% |